FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively enrolling patients. AD ...

Asthma is a form of bronchial disorder caused by inflammation of the bronchi. It is characterized by spasmodic contraction of airway smooth muscle, difficulty breathing, wheezing and coughing.

Methods to culture intestinal stem cells (ISCs) are often limited by undefined culture conditions arising from the use of basement membrane extracts or feeder cell layers. Here, the authors ...

Despite being the third biggest killer in the UK, lung conditions currently only receive 2.5% of public investment spent on ...

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day.

Research suggests that the centuries-old practice of tai chi, a slow-moving form ... with asthma comply with avoiding dust storms when exposure could trigger an attack, or how Fitbit data reflects ...

Biologics taken in combination with another form of treatment has been shown to be effective. Biologics work by interrupting immune system signals involved in the inflammatory process that result ...

This form of aversion has been noticed among the patients with asthma and AD, but it can be present with other conditions including CS medication within the treatment plan. Adherence to the ...

(CBS DETROIT) — At the end of 2025, Michigan Medicine will discontinue the University of Michigan Health Plan. The university, who announced the move on Wednesday, says the move will allow ...